The total effective rate of covid-19 specific medicine of traditional Chinese medicine, which can not be ignored, is more than 90% (with shares)

Zhang Wenhong interprets the new covid-19 diagnosis and treatment plan. He talked about three “weapons” to fight the epidemic: ① full injection of vaccine; ② We should have effective antiviral drugs and other drugs, including traditional Chinese medicine; ③ There is very sufficient medical redundancy.

Traditional Chinese medicine has played an active role in the prevention and treatment of covid-19. The clinical efficacy observation shows that the total effective rate of traditional Chinese medicine has reached more than 90%. On February 24, 2022, the conference on epidemic prevention and control in Suzhou introduced that the overall utilization rate of traditional Chinese medicine in this epidemic was 99.7%. According to the Research Report of securities companies, “integration of Chinese and Western medicine” will become the main treatment method of covid-19 in China: the epidemic situation in Hong Kong continues to worsen, and it is difficult to find a single drug of Lianhua Qingwen capsule for prevention and control. Hundreds of thousands of boxes of Lianhua Qingwen capsule and Xuanfei Baidu granules are also donated to Hong Kong urgently in many places in China. The prevention and control of covid-19 with traditional Chinese medicine has formed a consensus in Chinese society, We are optimistic about the future of “three drugs and three parties” and build covid-19 prevention and control walls with small molecules and neutralizing antibodies.

According to the theme database of financial Associated Press, among the relevant listed companies:

Xiangxue Pharmaceutical Co.Ltd(300147) product Xiangxue antiviral oral liquid was listed as epidemic prevention and control drugs by the government and undertook the task of storage during the severe epidemic period.

Zhejiang Wecome Pharmaceutical Company Limited(300878) Yuping wind dripping pills for Guangdong Health Protection Committee on the provision of COVID-19 pneumonia prevention and control materials reference list of medical institutions reference drug demand catalog species, honeysuckle soft capsule was included in Zhejiang province “temporarily incorporated into the net procurement New Coronavirus infection pneumonia diagnosis and treatment related drugs list” (three).

- Advertisment -